Conceptio
›
cell-death
Topic
cell-death
Knowledge-graph topic
· documents ABOUT cell-death across the archive
30
Documents about cell-death
Documents about cell-death
Apoptosis: A Review of Programmed Cell Death
#6788
OpenAlex
Unraveling the Intriguing Interplay: Exploring the Role of Lncrnas in Caspase-Independent Cell Death
#681777
İzmir Yüksek Teknoloji Enstitüsü
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
#6739
OpenAlex
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
#864360
ClinicalTrials.gov
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
#896290
ClinicalTrials.gov
Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)
#846086
ClinicalTrials.gov
Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)
#864543
ClinicalTrials.gov
Programmed cell death-1: from a T-cell immune checkpoint to a regulator of Natural Killer cell biology
#677814
IRIS
Nitric oxide induces p53-mediated cell death in human nasal epithelial cells
#385398
OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
Development and prognostic evaluation of an integrative programmed cell death index in pancreatic cancer based on multiple cell death modalities.
#154325
NCBI PubMed Central
A Deep‐Red‐Absorbing Osmium(II) Complex as a Photosensitizer for Photodynamic Therapy Inducing Immunogenic Cell Death
#175722
HAL (France)
PRRSV subverts host programmed cell death network for immune evasion
#4485
Europe PMC
Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis
#391871
HAL (France)
Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)
#994230
ClinicalTrials.gov
Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)
#991933
ClinicalTrials.gov
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)
#910133
ClinicalTrials.gov
KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)
#827772
ClinicalTrials.gov
Cytotoxicity unleashed: how Prymnesium parvum extract drives RTgill-W1 rainbow trout cells into cell death.
#136131
PubMed
REVIEW OF SIGNALING PATHWAYS AND MORPHOLOGICAL CHANGES OF PROGRAMMED CELL DEATH – APOPTOSIS
#237736
Zenodo (CERN)
Mitotic defects and cell death in sodium valproate-treated HeLa cells
#313098
Repositório de Dados de Pesquisa da Unicamp Dataverse OAI Archive
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
#899129
ClinicalTrials.gov
Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma
#834701
ClinicalTrials.gov
KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)
#1008511
ClinicalTrials.gov
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
#841484
ClinicalTrials.gov
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
#826923
ClinicalTrials.gov
Physiology in Cell Death Induction: Roles of Anion Channels and Disordered Cell Volume Regulation
#70229
J-STAGE (Japan)
Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
#851463
ClinicalTrials.gov
Raw Data
#318805
Figshare
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
#870636
ClinicalTrials.gov
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
#917769
ClinicalTrials.gov
Regulation of Programmed Cell Death During C. Elegans Development
#216392
EliScholar
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study
#914489
ClinicalTrials.gov
NOXA/MCL-1 axis determines cell-death decision between apoptosis and a GSDME-dependent cell death associated with production of inflammatory cytokines upon treatment of breast cancer cells with antimitotics
#284387
HAL (France)
A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)
#866337
ClinicalTrials.gov
Regulated Cell Death in Idiopathic Pulmonary Fibrosis.
#151406
NCBI PubMed Central
Regulated cell death in fungi from a comparative immunology perspective
#312032
HAL (France)
Senescent cells are more susceptible to reductive stress-induced cell death: implications for senolytic research.
#448038
bioRxiv / medRxiv
Partitioning of nuclear material into apoptotic fragments through establishment of asymmetric cell death morphology
#448041
bioRxiv / medRxiv
Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)
#859449
ClinicalTrials.gov
REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors
#174893
ClinicalTrials.gov
CLEM Data
#318806
Figshare
<i>PLoS Computational Biology</i> Issue Image | Vol. 22(6) July 2026
#351930
PLOS
Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma
#915074
ClinicalTrials.gov
A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)
#843087
ClinicalTrials.gov
Unmasking programmed cell death in rhinovirus-driven asthma pathology
#666962
Spiral
Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck
#947660
Repositorio de Universidad Autónoma de Chile.
Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)
#877826
ClinicalTrials.gov
Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress
#458456
Europe PMC
Table1_Hesperidin Ameliorates Dexamethasone-Induced Osteoporosis by Inhibiting p53.XLSX
#405482
Figshare
A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)
#968715
ClinicalTrials.gov
Page 1 of 5
Next →
Related topics
adhd
4
adolescents
4
africa
4
aging
4
air-pollution
4
alzheimer-s-disease
4
antibiotic-resistance
4
antibiotics
4
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.